Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1951 1
1952 1
1954 1
1955 1
1958 1
1964 1
1966 1
1967 1
1970 1
1972 1
1983 1
1985 2
1986 3
1987 2
1988 2
1989 9
1990 9
1991 7
1992 9
1993 9
1994 19
1995 23
1996 19
1997 13
1998 22
1999 16
2000 19
2001 12
2002 13
2003 17
2004 8
2005 8
2006 5
2007 3
2008 7
2009 8
2010 3
2011 7
2012 3
2013 3
2014 2
2015 5
2016 3
2017 4
2018 4
2019 9
2020 8
2021 9
2022 8
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

332 results

Results by year

Filters applied: . Clear all
Page 1
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape.
Hegde M, Mukherjee M, Grada Z, Pignata A, Landi D, Navai SA, Wakefield A, Fousek K, Bielamowicz K, Chow KK, Brawley VS, Byrd TT, Krebs S, Gottschalk S, Wels WS, Baker ML, Dotti G, Mamonkin M, Brenner MK, Orange JS, Ahmed N. Hegde M, et al. Among authors: wakefield a. J Clin Invest. 2016 Aug 1;126(8):3036-52. doi: 10.1172/JCI83416. Epub 2016 Jul 18. J Clin Invest. 2016. PMID: 27427982 Free PMC article.
HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial.
Ahmed N, Brawley V, Hegde M, Bielamowicz K, Kalra M, Landi D, Robertson C, Gray TL, Diouf O, Wakefield A, Ghazi A, Gerken C, Yi Z, Ashoori A, Wu MF, Liu H, Rooney C, Dotti G, Gee A, Su J, Kew Y, Baskin D, Zhang YJ, New P, Grilley B, Stojakovic M, Hicks J, Powell SZ, Brenner MK, Heslop HE, Grossman R, Wels WS, Gottschalk S. Ahmed N, et al. Among authors: wakefield a. JAMA Oncol. 2017 Aug 1;3(8):1094-1101. doi: 10.1001/jamaoncol.2017.0184. JAMA Oncol. 2017. PMID: 28426845 Free PMC article. Clinical Trial.
MMR--responding to retraction.
Wakefield AJ, Harvey P, Linnell J. Wakefield AJ, et al. Lancet. 2004 Apr 17;363(9417):1327-8; discussion 1328. doi: 10.1016/S0140-6736(04)16017-0. Lancet. 2004. PMID: 15094289 No abstract available.
Mapping the binding sites of challenging drug targets.
Wakefield AE, Kozakov D, Vajda S. Wakefield AE, et al. Curr Opin Struct Biol. 2022 Aug;75:102396. doi: 10.1016/j.sbi.2022.102396. Epub 2022 May 27. Curr Opin Struct Biol. 2022. PMID: 35636004 Free PMC article. Review.
A statement by Dr Andrew Wakefield.
Wakefield A. Wakefield A. Lancet. 2004 Mar 6;363(9411):823-4. doi: 10.1016/S0140-6736(04)15710-3. Lancet. 2004. PMID: 15022650 No abstract available.
Fulminant hepatitis.
Sinclair S, Wakefield A, Levy G. Sinclair S, et al. Among authors: wakefield a. Springer Semin Immunopathol. 1990;12(1):33-45. doi: 10.1007/BF00192680. Springer Semin Immunopathol. 1990. PMID: 1695027 Free PMC article. Review.
Pneumocystis carinii.
Wakefield AE. Wakefield AE. Br Med Bull. 2002;61:175-88. doi: 10.1093/bmb/61.1.175. Br Med Bull. 2002. PMID: 11997305 Review.
332 results